We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+12.52%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$427M
AUM Growth
+$187M
Cap. Flow
+$161M
Cap. Flow %
37.84%
Top 10 Hldgs %
59.81%
Holding
55
New
16
Increased
13
Reduced
16
Closed
8

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$15.3M
2
CRL icon
Charles River Laboratories
CRL
+$5.97M
3
EW icon
Edwards Lifesciences
EW
+$5.88M
4
BAX icon
Baxter International
BAX
+$5.29M
5
AVTR icon
Avantor
AVTR
+$5.09M

Top Sells

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$6.88M
2
MDT icon
Medtronic
MDT
+$6.59M
3
THC icon
Tenet Healthcare
THC
+$6.29M
4
ZBH icon
Zimmer Biomet
ZBH
+$6.08M
5
DVA icon
DaVita
DVA
+$4.71M

Sector Composition

Rank Sector Weight
1 Healthcare 57.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CAH icon
26
Cardinal Health
CAH
$54.5B
$5.04M 1.18%
45,000
+5,000
+13% +$539K
BMRN icon
27
BioMarin Pharmaceuticals
BMRN
$13.6B
$5.02M 1.18%
57,500
+2,500
+5% +$224K
EHC icon
28
Encompass Health
EHC
$12.3B
$4.96M 1.16%
60,000
-30,000
-33% -$2.2M
UNH icon
29
UnitedHealth
UNH
$364B
$4.95M 1.16%
10,000
– –
DXCM icon
30
DexCom
DXCM
$34.3B
$4.86M 1.14%
35,000
-15,000
-30% -$1.89M
VRTX icon
31
Vertex Pharmaceuticals
VRTX
$133B
$4.6M 1.08%
11,000
-1,500
-12% -$634K
WST icon
32
West Pharmaceutical
WST
$24.8B
$3.96M 0.93%
+10,000
New +$3.7M
BDX icon
33
Becton Dickinson
BDX
$50B
$3.71M 0.87%
+15,000
New +$3.59M
OPCH icon
34
Option Care Health
OPCH
$3.57B
$3.69M 0.86%
+110,000
New +$3.56M
GEHC icon
35
GE HealthCare
GEHC
$32.6B
$3.64M 0.85%
+40,000
New +$3.33M
CI icon
36
Cigna
CI
$73.3B
$3.63M 0.85%
10,000
-7,500
-43% -$2.47M
NTRA icon
37
Natera
NTRA
$45.5B
$3.2M 0.75%
+35,000
New +$2.63M
MRVI icon
38
Maravai LifeSciences
MRVI
$861M
$3.17M 0.74%
365,000
+159,759
+78% +$1.08M
RVTY icon
39
Revvity
RVTY
$13.2B
$3.15M 0.74%
+30,000
New +$3.19M
MEDP icon
40
Medpace
MEDP
$16.7B
$3.03M 0.71%
+7,500
New +$2.64M
CTLT
41
DELISTED
CATALENT, INC.
CTLT
$2.82M 0.66%
+50,000
New +$2.71M
STVN icon
42
Stevanato
STVN
$5.8B
$2.67M 0.63%
83,039
+3,039
+4% +$92.5K
TEVA icon
43
Teva Pharmaceuticals
TEVA
$42.8B
$2.47M 0.58%
+175,000
New +$2.21M
BNTX icon
44
BioNTech
BNTX
$23.3B
$2.31M 0.54%
+25,000
New +$2.4M
BIIB icon
45
Biogen
BIIB
$30.9B
$2.16M 0.51%
10,034
-14,966
-60% -$3.51M
GPCR icon
46
Structure Therapeutics
GPCR
$3.83B
$191K 0.04%
+4,464
New +$188K
COR icon
47
Cencora
COR
$60B
– –
-20,000
Closed -$4.11M
DGX icon
48
Quest Diagnostics
DGX
$26.2B
– –
-30,000
Closed -$4.14M
DVA icon
49
DaVita
DVA
$11.6B
– –
-45,000
Closed -$4.71M
LH icon
50
Labcorp
LH
$26.2B
– –
-15,000
Closed -$3.41M
1
2
3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return
CIP
Castlefield Investment Partners Manchester $131M AUM

Sivik Global Healthcare's Q1 2024 Portfolio in Review

As of Q1 2024, Sivik Global Healthcare held 55 positions worth $427M, up 78% from $239M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Sivik Global Healthcare deployed $161M of net new capital in Q1 2024, opening 16 new positions and adding to 13 existing holdings. Its largest new stake was Charles River Laboratories: 25,000 shares worth $6.77M.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, down from 95% a quarter earlier.

On the sell side, the largest reduction was HCA Healthcare, an estimated $6.88M trimmed.

  • Sivik Global Healthcare's largest Q1 2024 buy was Charles River Laboratories: 25,000 shares worth $6.77M.
  • Sivik Global Healthcare added most to State Street SPDR S&P Biotech ETF in Q1 2024, an estimated $15.3M increase.
  • Sivik Global Healthcare's biggest Q1 2024 reduction was HCA Healthcare, cutting an estimated $6.88M.
  • Sivik Global Healthcare fully exited Medtronic in Q1 2024, selling an estimated $6.59M.
  • Sivik Global Healthcare's ten largest holdings make up 60% of its $427M portfolio in Q1 2024.
  • Sivik Global Healthcare opened 16 new positions and closed 8 in Q1 2024.
  • Sivik Global Healthcare's portfolio value rose 78% quarter-over-quarter to $427M.

Based on Sivik Global Healthcare's 13F filing for Q1 2024, filed 1 May 2024.